Free Trial

Analysts Set PACS Group, Inc. (NYSE:PACS) Price Target at $34.00

PACS Group logo with Medical background
Remove Ads

Shares of PACS Group, Inc. (NYSE:PACS - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $34.00.

PACS has been the subject of several recent research reports. Macquarie dropped their price objective on shares of PACS Group from $42.00 to $24.00 and set an "outperform" rating for the company in a research report on Monday, January 6th. Stephens lowered their price target on shares of PACS Group from $48.00 to $31.00 and set an "overweight" rating for the company in a report on Monday, November 18th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $18.00 price target on shares of PACS Group in a report on Tuesday, December 17th. Finally, Truist Financial lowered their price target on shares of PACS Group from $46.00 to $32.00 and set a "buy" rating for the company in a report on Monday, January 6th.

Get Our Latest Analysis on PACS

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Amalgamated Bank lifted its position in shares of PACS Group by 56.7% in the 3rd quarter. Amalgamated Bank now owns 1,349 shares of the company's stock worth $54,000 after buying an additional 488 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of PACS Group by 2.5% in the 4th quarter. Rhumbline Advisers now owns 50,540 shares of the company's stock worth $663,000 after acquiring an additional 1,217 shares during the period. MetLife Investment Management LLC increased its holdings in shares of PACS Group by 6.6% in the 4th quarter. MetLife Investment Management LLC now owns 24,539 shares of the company's stock worth $322,000 after acquiring an additional 1,527 shares during the period. Crewe Advisors LLC acquired a new stake in shares of PACS Group in the 3rd quarter worth about $66,000. Finally, Wells Fargo & Company MN increased its holdings in shares of PACS Group by 6.8% in the 4th quarter. Wells Fargo & Company MN now owns 34,317 shares of the company's stock worth $450,000 after acquiring an additional 2,196 shares during the period.

Remove Ads

PACS Group Stock Performance

Shares of PACS Group stock traded up $0.38 during trading hours on Friday, hitting $13.26. The company's stock had a trading volume of 321,975 shares, compared to its average volume of 547,709. PACS Group has a 1-year low of $12.38 and a 1-year high of $43.92. The business has a fifty day moving average of $13.59 and a 200 day moving average of $24.69. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.71 and a quick ratio of 1.71.

PACS Group Company Profile

(Get Free Report

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Featured Stories

Analyst Recommendations for PACS Group (NYSE:PACS)

Should You Invest $1,000 in PACS Group Right Now?

Before you consider PACS Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.

While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up
Tesla Sinks on Musk Drama—Bounce or Bigger Crash?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads